Trial Profile
Prospective, Systematic Observational Study on the Daily Use of Cilostazol (Pletal®) in Clinical Vascular Surgical Practice – Significant Improvement of Walking Distance and Quality of Life for Patients with PAOD, Stage II b - /
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2017
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Peripheral arterial occlusive disorders
- Focus Therapeutic Use
- 09 Feb 2017 New trial record